Leerink Partnrs Has Bullish Forecast for EHC Q1 Earnings

Encompass Health Co. (NYSE:EHC) – Analysts at Leerink Partnrs increased their Q1 2025 earnings per share estimates for Encompass Health in a research report issued on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $1.26 for the quarter, up from their prior forecast of $1.21. The consensus estimate for Encompass Health’s current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Encompass Health’s Q3 2025 earnings at $1.15 EPS, Q4 2025 earnings at $1.30 EPS, FY2025 earnings at $4.90 EPS, Q1 2026 earnings at $1.29 EPS, Q3 2026 earnings at $1.17 EPS, Q4 2026 earnings at $1.34 EPS and FY2026 earnings at $5.01 EPS.

A number of other equities analysts also recently weighed in on the company. Barclays boosted their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. Royal Bank of Canada reissued an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. KeyCorp lifted their target price on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday. Finally, StockNews.com lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday, February 7th. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $107.67.

Encompass Health Stock Up 0.7 %

Encompass Health stock opened at $99.37 on Wednesday. Encompass Health has a fifty-two week low of $72.38 and a fifty-two week high of $104.55. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm’s 50-day simple moving average is $96.14 and its 200 day simple moving average is $95.41. The stock has a market cap of $10.01 billion, a PE ratio of 22.28, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%.

Institutional Investors Weigh In On Encompass Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new position in Encompass Health during the fourth quarter worth about $77,944,000. Point72 Asset Management L.P. lifted its stake in shares of Encompass Health by 2,458.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after buying an additional 835,135 shares in the last quarter. Jennison Associates LLC bought a new position in Encompass Health in the 4th quarter worth approximately $52,094,000. abrdn plc purchased a new position in Encompass Health in the 4th quarter valued at approximately $17,846,000. Finally, Thrivent Financial for Lutherans raised its holdings in Encompass Health by 26.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after acquiring an additional 156,938 shares during the period. 97.25% of the stock is currently owned by institutional investors.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.